Tis the season.... there is a glut of patients with symptoms related to seasonal allergies. Of course, patients seem to be talking about red, itchy eyes as their primary symptom, while you may be hearing more about systemic and respiratory symptoms.Some interesting s...

An estimated 20% of the world’s population suffers from allergic disease and may present as red itchy eyes, rhinitis (runny nose), asthma, and allergic conjunctivitis.Ocular allergies are specific immunologic changes that result in inflammation on the conjunctival sur...

HUENENBERG, Switzerland -- Alcon, Inc. (NYSE:ACL) reported global sales of $1,536.4 million for the first quarter of 2008, an increase of 16.2 percent compared to the first quarter of 2007, or 9.4 percent excluding the impact of foreign exchange fluctuations. Net...

HUENENBERG, Switzerland -- Alcon, Inc. (NYSE:ACL) reported global sales of $1,735.2 million for the second quarter of 2008, an increase of 17.9 percent compared to the second quarter of 2007, or 11.2 percent excluding the impact of foreign exchange fluctuations. ...

HUENENBERG, Switzerland -- Alcon, Inc. (NYSE:ACL) announced today that Gerald D. Cagle, Ph.D., Alcon's senior vice president of Research and Development and chief scientific officer, will be retiring from the company on June 30, 2008, after 32 years of dedicated ...

HUENENBERG, Switzerland -- Alcon, Inc. (NYSE: ACL) announced today that it has submitted to the U.S. Food and Drug Administration (FDA) an amendment to its pending new drug application (NDA) for PATANASE([R]) (olopatadine hydrochloride) nasal spray. The pending N...

HUNENBERG, Switzerland -- Alcon, Inc. (NYSE:ACL) reported global sales of $1,471.5 million for the second quarter of 2007, an increase of 12.3 percent over global sales for the second quarter of 2006, or 10.0 percent on a constant currency basis. Net earnings for...

HUNENBERG, Switzerland -- Alcon, Inc. (NYSE:ACL) reported global sales of $1,335.7 million for the third quarter of 2007, an increase of 11.0 percent over global sales for the third quarter of 2006, or 7.9 percent on a constant currency basis. Net earnings for th...

HUENENBERG, Switzerland -- At the 2007 American Association of Retired Persons (AARP) Annual Meeting in Boston last month, Alcon, Inc. (NYSE:ACL), the world's largest eye care company, joined with the nation's leading volunteer eye health organization, Prevent B...

HUNENBERG, Switzerland -- Alcon, Inc. (NYSE:ACL) reported global sales of $1,224.9 million for the fourth quarter of 2006, an increase of 16.1 percent over global sales for the fourth quarter of 2005, or 13.5 percent excluding the impact of foreign exchange fluctua...

HUENENBERG, Switzerland -- Alcon, Inc. (NYSE:ACL) reported global sales of $1,536.4 million for the first quarter of 2008, an increase of 16.2 percent compared to the first quarter of 2007, or 9.4 percent excluding the impact of foreign exchange fluctuations. Net earn...

HUENENBERG, Switzerland -- Alcon, Inc. (NYSE:ACL) announced today that Gerald D. Cagle, Ph.D., Alcon's senior vice president of Research and Development and chief scientific officer, will be retiring from the company on June 30, 2008, after 32 years of dedicated servi...

FORT WORTH, Texas -- Prevent Blindness Texas - Fort Worth Branch, an affiliate of Prevent Blindness America, the nation's leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight, has chosen Gerald D. Cagle, Ph.D. as the re...